Nature Communications, 2023 · DOI: 10.1038/s41467-023-37585-8 · Published: April 14, 2023
This study identifies a genetic cause for a rare and severe form of heterotopic ossification (HO), where soft tissues turn into bone. The condition is linked to a structural variant that leads to the misexpression of a gene called ARHGAP36 in fibroblasts. The researchers found that the abnormal activation of ARHGAP36 interferes with important signaling pathways involved in bone formation, such as TGFβ and hedgehog signaling, and also affects the production of the extracellular matrix. This research provides new insights into the role of ARHGAP36 in bone formation and metabolism, contributing to a better understanding of the genetic factors involved in bone disorders and potential future gene therapies.
ARHGAP36 could be a target for therapies aimed at preventing or treating heterotopic ossification.
The genetic variant could be used as a diagnostic marker for this specific type of HO.
The study contributes to understanding the complex genetic and molecular mechanisms involved in bone formation and related disorders.